Transition Metal-Based Therapies for Inflammatory Diseases

Area of Science:

• Nanomedicine
• Materials Science
• Immunology

Background:

• Inflammatory diseases (IDs) involve chronic inflammation, with current therapies offering only palliative care and short-term relief.
• Nanodrugs present a promising avenue for addressing the root causes of IDs and preventing disease recurrence.
• Transition metal-based smart nanosystems (TMSNs) exhibit unique properties beneficial for treating inflammatory conditions.

Purpose of the Study:

• To review the rationale, design principles, and therapeutic mechanisms of TMSNs for treating various inflammatory diseases.
• To highlight the potential of TMSNs in addressing the underlying causes and preventing recurrence of inflammatory conditions.
• To discuss the future clinical applications of TMSN-based therapies for inflammatory diseases.

Main Methods:

• Review of existing literature on transition metal-based smart nanosystems (TMSNs) for inflammatory disease treatment.
• Analysis of TMSNs' unique electronic structures, large surface area-to-volume ratio, photothermal conversion efficiency, X-ray absorption, and catalytic enzyme activities.
• Exploration of TMSNs' capabilities in scavenging danger signals and blocking inflammatory response mechanisms.

Main Results:

• TMSNs can be designed to scavenge danger signals like reactive oxygen species, nitrogen species, and cell-free DNA.
• TMSNs can be engineered to inhibit the initiation of inflammatory responses.
• TMSNs serve as effective nanocarriers for delivering anti-inflammatory drugs, enhancing therapeutic efficacy.

Conclusions:

• Transition metal-based smart nanosystems (TMSNs) demonstrate significant therapeutic advantages for inflammatory diseases (IDs).
• TMSNs offer multifaceted treatment strategies including signal scavenging, inflammation blocking, and drug delivery.
• Further research and development of TMSNs hold great promise for the clinical management of inflammatory diseases.